Ledger.Open graph →
SEC Form D · filed November 4, 2016

CRISPR Therapeutics AG

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
BASEL, V8
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (26)

Kurt J. Von Emster · Basel, V8DirectorSven A. Lundberg · Cambridge, MAExecThomas J. Woiwode · Basel, V8DirectorAli A. Behbahani · Basel, V8DirectorBradley A. Bolzon · Basel, V8DirectorSamarth A. Kulkarni · Cambridge, MAExecSimeon J. George · Basel, V8DirectorRodger Novak · Basel, V8Exec · DirectorPablo J. Cagnoni · Basel, V8DirectorN. A. Coles · Basel, V8DirectorKala A. Subramanian · Cambridge, MAExecMarc J. Becker · Cambridge, MAExecTyler A. Dylan-Hyde · Cambridge, MAExecKurt J. Von Emster · Basel, V8DirectorSven A. Lundberg · Cambridge, MAExecThomas J. Woiwode · Basel, V8DirectorAli A. Behbahani · Basel, V8DirectorRodger Novak · Basel, V8Exec · DirectorPablo J. Cagnoni · Basel, V8DirectorBradley A. Bolzon · Basel, V8DirectorN. A. Coles · Cambridge, MADirectorKala A. Subramanian · Cambridge, MAExecSamarth A. Kulkarni · Cambridge, MAExecMarc J. Becker · Cambridge, MAExecSimeon J. George · Basel, V8DirectorTyler A. Dylan-Hyde · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗